Mass transfer in hollow fiber-type artificial pancreas devices

G. M. Vélez, C. L. Stephens, L. Y. Santiago, G. López, R. F. Boyd, Andrew Zydney, C. A. Ramírez

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The insulin-dependent (type I) diabetic population is increasing worldwide at an alarming rate, with no permanent cure foreseen in the near future. A promising alternative to insulin injection therapy is the intravascular hybrid artificial pancreas (HAP), which consists of an inert cylindrical housing enclosing a single, tubular semipermeable hollow fiber membrane epoxied at the ends. Donor islets of Langerhans can be seeded in the annular space, and are thus protected from the recipient's immune system HAP-type devices were proposed in the early 1970s, but have not reached the clinical stage due to lack of scale-up criteria The goal of this project was to establish design criteria for HAPs based on classical chemical engineering principles which would allow their use in human diabetics One approach involved the in vitro perfusion of HAPs in which the annular compartment was initially filled with a glucose solution of known concentration. A washout experiment was then conducted by perfusing the HAP with solute-free buffer The glucose washout time was found to depend on flow rate, device dimensions, membrane fouling with bovine serum albumin, and the presence of glass beads in the annular space representing islets HAP performance was also analyzed using a theoretical transport model which accounts for both solute convection and diffusion in all three regions of the HAP (lumen, membrane, and annular space). The model was found to be in very good agreement with the glucose washout data Our results show that mass transfer in the HAP is very complex; but that through the rational design of experiments and mathematical simulations one can obtain new insights into the solute transport behavior ultimately leading to devices suitable for human use.

Original languageEnglish (US)
JournalFASEB Journal
Volume11
Issue number3
StatePublished - 1997

Fingerprint

Artificial Pancreas
mass transfer
pancreas
Mass transfer
Glucose
Equipment and Supplies
Fibers
Insulin
Membranes
Solute transport
Membrane fouling
Immune system
Chemical engineering
Bovine Serum Albumin
Design of experiments
glucose
solutes
Buffers
insulin
Flow rate

All Science Journal Classification (ASJC) codes

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

Vélez, G. M., Stephens, C. L., Santiago, L. Y., López, G., Boyd, R. F., Zydney, A., & Ramírez, C. A. (1997). Mass transfer in hollow fiber-type artificial pancreas devices. FASEB Journal, 11(3).
Vélez, G. M. ; Stephens, C. L. ; Santiago, L. Y. ; López, G. ; Boyd, R. F. ; Zydney, Andrew ; Ramírez, C. A. / Mass transfer in hollow fiber-type artificial pancreas devices. In: FASEB Journal. 1997 ; Vol. 11, No. 3.
@article{d0799764526644e08c709ac0ee4b3a5f,
title = "Mass transfer in hollow fiber-type artificial pancreas devices",
abstract = "The insulin-dependent (type I) diabetic population is increasing worldwide at an alarming rate, with no permanent cure foreseen in the near future. A promising alternative to insulin injection therapy is the intravascular hybrid artificial pancreas (HAP), which consists of an inert cylindrical housing enclosing a single, tubular semipermeable hollow fiber membrane epoxied at the ends. Donor islets of Langerhans can be seeded in the annular space, and are thus protected from the recipient's immune system HAP-type devices were proposed in the early 1970s, but have not reached the clinical stage due to lack of scale-up criteria The goal of this project was to establish design criteria for HAPs based on classical chemical engineering principles which would allow their use in human diabetics One approach involved the in vitro perfusion of HAPs in which the annular compartment was initially filled with a glucose solution of known concentration. A washout experiment was then conducted by perfusing the HAP with solute-free buffer The glucose washout time was found to depend on flow rate, device dimensions, membrane fouling with bovine serum albumin, and the presence of glass beads in the annular space representing islets HAP performance was also analyzed using a theoretical transport model which accounts for both solute convection and diffusion in all three regions of the HAP (lumen, membrane, and annular space). The model was found to be in very good agreement with the glucose washout data Our results show that mass transfer in the HAP is very complex; but that through the rational design of experiments and mathematical simulations one can obtain new insights into the solute transport behavior ultimately leading to devices suitable for human use.",
author = "V{\'e}lez, {G. M.} and Stephens, {C. L.} and Santiago, {L. Y.} and G. L{\'o}pez and Boyd, {R. F.} and Andrew Zydney and Ram{\'i}rez, {C. A.}",
year = "1997",
language = "English (US)",
volume = "11",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "3",

}

Vélez, GM, Stephens, CL, Santiago, LY, López, G, Boyd, RF, Zydney, A & Ramírez, CA 1997, 'Mass transfer in hollow fiber-type artificial pancreas devices', FASEB Journal, vol. 11, no. 3.

Mass transfer in hollow fiber-type artificial pancreas devices. / Vélez, G. M.; Stephens, C. L.; Santiago, L. Y.; López, G.; Boyd, R. F.; Zydney, Andrew; Ramírez, C. A.

In: FASEB Journal, Vol. 11, No. 3, 1997.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Mass transfer in hollow fiber-type artificial pancreas devices

AU - Vélez, G. M.

AU - Stephens, C. L.

AU - Santiago, L. Y.

AU - López, G.

AU - Boyd, R. F.

AU - Zydney, Andrew

AU - Ramírez, C. A.

PY - 1997

Y1 - 1997

N2 - The insulin-dependent (type I) diabetic population is increasing worldwide at an alarming rate, with no permanent cure foreseen in the near future. A promising alternative to insulin injection therapy is the intravascular hybrid artificial pancreas (HAP), which consists of an inert cylindrical housing enclosing a single, tubular semipermeable hollow fiber membrane epoxied at the ends. Donor islets of Langerhans can be seeded in the annular space, and are thus protected from the recipient's immune system HAP-type devices were proposed in the early 1970s, but have not reached the clinical stage due to lack of scale-up criteria The goal of this project was to establish design criteria for HAPs based on classical chemical engineering principles which would allow their use in human diabetics One approach involved the in vitro perfusion of HAPs in which the annular compartment was initially filled with a glucose solution of known concentration. A washout experiment was then conducted by perfusing the HAP with solute-free buffer The glucose washout time was found to depend on flow rate, device dimensions, membrane fouling with bovine serum albumin, and the presence of glass beads in the annular space representing islets HAP performance was also analyzed using a theoretical transport model which accounts for both solute convection and diffusion in all three regions of the HAP (lumen, membrane, and annular space). The model was found to be in very good agreement with the glucose washout data Our results show that mass transfer in the HAP is very complex; but that through the rational design of experiments and mathematical simulations one can obtain new insights into the solute transport behavior ultimately leading to devices suitable for human use.

AB - The insulin-dependent (type I) diabetic population is increasing worldwide at an alarming rate, with no permanent cure foreseen in the near future. A promising alternative to insulin injection therapy is the intravascular hybrid artificial pancreas (HAP), which consists of an inert cylindrical housing enclosing a single, tubular semipermeable hollow fiber membrane epoxied at the ends. Donor islets of Langerhans can be seeded in the annular space, and are thus protected from the recipient's immune system HAP-type devices were proposed in the early 1970s, but have not reached the clinical stage due to lack of scale-up criteria The goal of this project was to establish design criteria for HAPs based on classical chemical engineering principles which would allow their use in human diabetics One approach involved the in vitro perfusion of HAPs in which the annular compartment was initially filled with a glucose solution of known concentration. A washout experiment was then conducted by perfusing the HAP with solute-free buffer The glucose washout time was found to depend on flow rate, device dimensions, membrane fouling with bovine serum albumin, and the presence of glass beads in the annular space representing islets HAP performance was also analyzed using a theoretical transport model which accounts for both solute convection and diffusion in all three regions of the HAP (lumen, membrane, and annular space). The model was found to be in very good agreement with the glucose washout data Our results show that mass transfer in the HAP is very complex; but that through the rational design of experiments and mathematical simulations one can obtain new insights into the solute transport behavior ultimately leading to devices suitable for human use.

UR - http://www.scopus.com/inward/record.url?scp=33645313034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645313034&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33645313034

VL - 11

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 3

ER -

Vélez GM, Stephens CL, Santiago LY, López G, Boyd RF, Zydney A et al. Mass transfer in hollow fiber-type artificial pancreas devices. FASEB Journal. 1997;11(3).